KB-R7785 | MedChemExpress (MCE)
KB-R7785 is a novel matrix metalloproteinase (MMP) inhibitor, which improves insulin sensitivity by inhibiting TNF-α production. KB-R7785 can be used for diabetes research. KB-R7785 has a protective efficacy against focal cerebral ischemia[1][2].
| Trivial name | KB-R7785 |
| Catalog Number | HY-142069 |
| Research Area | Endocrinology |
| CAS# | 168158-16-5 |
| Purity | ≥98.00% |
| SMILES | ONC([C@@H](C)[C@@H](CC(C)C)C(N[C@@H](C1=CC=CC=C1)C(NC)=O)=O)=O |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/kb-r7785.html |